Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Big effect

Pomegranate supplementation linked to a 0.39 mmHg drop in diastolic blood pressure in a meta-analysis — but other heart risk markers didn't budge

This is one of the first large-scale analyses to suggest pomegranate may lower diastolic pressure, but the effect is modest (less than half a millimeter of mercury) and the same analysis found no improvement in insulin resistance or waist-to-hip ratio, so the overall picture is still uncertain.

Diastolic blood pressure is the bottom number in a reading, reflecting pressure when the heart rests between beats. A meta-analysis of 53 trials found a small but statistically significant reduction of 0.39 mmHg with pomegranate supplementation. However, other measures like waist-to-hip ratio and insulin resistance showed no change, and because this is among the first indexed studies on the pairing, more research is needed before drawing firm conclusions.

Where this fits in the evidence

This is among the first studies we've indexed on pomegranate for Reduced Diastolic Blood Pressure — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top